Charles C. Williams

发表

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors

C. Slapak, D. Spriggs, E. Haura, 2011, Cancer Chemotherapy and Pharmacology.

NCCN Small Cell Lung Cancer Clinical Practice Guidelines in Oncology

C. Rudin, R. Govindan, B. Loo, 2013 .

A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma

C. Ryan, C. Kaiser, D. Alwis, 2013, Investigational New Drugs.

Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer

John W. Adams, M. Berger, M. Edelman, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Increased Bioavailability of Intravenous Versus Oral CI-1033, a Pan erbB Tyrosine Kinase Inhibitor: Results of a Phase I Pharmacokinetic Study

G. Bepler, M. Fishman, P. Munster, 2006, Clinical Cancer Research.

Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution.

G. Bepler, A. Cantor, E. Haura, 2003, Cancer control : journal of the Moffitt Cancer Center.

Gefitinib ( ZD 1839 ) in Previously Treated Advanced Non – Small-Cell Lung Cancer : Experience From a Single Institution

G. Bepler, A. Cantor, E. Haura, 2003 .

Malignant pleural mesothelioma: a comprehensive review.

G. Bepler, C. Garrett, G. Simon, 2006, Cancer control : journal of the Moffitt Cancer Center.

Small Cell Lung Cancer

C. Rudin, R. Govindan, R. Heist, 2016, Seminars in Respiratory and Critical Care Medicine.

Small cell lung cancer.

Renato Martins, Nithya Ramnath, Bruce E Johnson, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Phase II Study of First-Line Sequential Chemotherapy with Gemcitabine-Carboplatin Followed by Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer

G. Bepler, E. Haura, G. Simon, 2005, Oncology.

Malignant localized fibrous tumor of the pleura.

Charles C. Williams, Leah B. Strickland-Marmol, A. Khoor, 2002, Cancer control : journal of the Moffitt Cancer Center.

Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer.

Eric B Haura, Bhupendra Rawal, Michael J Schell, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors

G. Gibney, J. Markowitz, E. Haura, 2017, OncoTargets and therapy.

Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer

G. Bepler, E. Haura, Dung-Tsa Chen, 2018, Cancer Immunology, Immunotherapy.

Small Cell Lung Cancer

C. Rudin, R. Govindan, B. Loo, 2022 .

Small Cell Lung CancerPractice Guidelines in Oncology

C. Rudin, R. Govindan, B. Loo, 2011 .

A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors

G. Bepler, M. Schell, S. Altiok, 2014, Clinical Cancer Research.

Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer.

G. Bepler, M. Schell, S. Gadgeel, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment‐use trial of sunitinib

G. Demetri, H. Hurwitz, Yoon-Koo Kang, 2015, Cancer.

Phase 2 trial of docetaxel and gefitinib in the first‐line treatment of patients with advanced nonsmall‐cell lung cancer (NSCLC) who are 70 years of age or older

Eric B Haura, Michael J Schell, Rachna Kapoor, 2008, Cancer.

Phase I Study of a Novel Taxane BMS-188797 in Adult Patients with Solid Malignancies

M. Fishman, W. Dalton, D. Sullivan, 2005, Clinical Cancer Research.

Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trial

M. Fishman, A. Cantor, P. Munster, 2006, Molecular Cancer Therapeutics.

Small cell lung cancer clinical practice guidelines in oncology.

D. Ettinger, J. Crawford, F. Fossella, 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.

B. Loo, R. Heist, J. Hayman, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.

Alan Cantor, Frank Walsh, George Simon, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)

G. Bepler, D. Gandara, J. Moon, 2014, Cancer.

Clinical Efficacy and Predictive Molecular Markers of Neoadjuvant Gemcitabine and Pemetrexed in Resectable Non-small Cell Lung Cancer

C. Obasaju, G. Bepler, A. Cantor, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase II Trial of a GM-CSF-producing and CD40L-expressing Bystander Cell Line Combined With an Allogeneic Tumor Cell–based Vaccine for Refractory Lung Adenocarcinoma

G. Bepler, M. Schell, E. Haura, 2013, Journal of immunotherapy.

Phase 2 study of concurrent cetuximab plus definitive thoracic radiation therapy followed by consolidation docetaxel plus cetuximab in poor prognosis or elderly patients with locally advanced non-small cell lung cancer.

C. Stevens, T. Dilling, E. Haura, 2014, International journal of radiation oncology, biology, physics.

A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma

S. Altiok, E. Haura, Jongphil Kim, 2018, Cancer Immunology, Immunotherapy.

The Guinea Pig Syndrome: Improving Clinical Trial Participation among Thoracic Patients

G. Bepler, B. Bell, G. Quinn, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lung Cancer Patients’ Decisions About Clinical Trials and the Theory of Planned Behavior

G. Bepler, G. Quinn, Charles C. Williams, 2011, Journal of Cancer Education.

Safety , pharmacokinetics , and pharmacodynamics of oral omaveloxolone ( rTa 408 ) , a synthetic triterpenoid , in a first-inhuman trial of patients with advanced solid tumors

G. Gibney, J. Markowitz, E. Haura, 2017 .

Phase I/II Study of Atrasentan, an Endothelin A Receptor Antagonist, in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Advanced Non–Small Cell Lung Cancer

G. Bepler, D. Boulware, D. Sullivan, 2008, Clinical Cancer Research.

Phase II Trial of Induction Gemcitabine and Carboplatin Followed by Conformal Thoracic Radiation to 74 Gy with Weekly Paclitaxel and Carboplatin in Unresectable Stage III Non-small Cell Lung Cancer

G. Bepler, C. Stevens, T. Dilling, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Docetaxel and gefitinib in the first-line treatment of elderly patients (≥70) with advanced non-small cell lung cancer (ANSCLC): Results of phase II trial

G. Bepler, E. Haura, T. Galloway, 2005 .

Phase I/II study of the A2AR antagonist NIR178 (PBF-509), an oral immunotherapy, in patients (pts) with advanced NSCLC.

E. Morris, E. Haura, A. Beg, 2018 .

Patient, caregiver and physician perspectives on participating in a thoracic rapid tissue donation program.

M. Schabath, E. Haura, G. Quinn, 2017, Patient education and counseling.

A phase I/II randomized trial using GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) vaccine in combination with CCL21 in stage IV lung adenocarcinoma: Preliminary results.

E. Haura, Jongphil Kim, Charles C. Williams, 2013 .

Phase II trial of bexarotene capsules in patients with advanced non-small-cell lung cancer after failure of two or more previous therapies.

J. Crowley, R. Govindan, V. Bolejack, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I/Ib study of pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC).

E. Haura, A. Beg, Charles C. Williams, 2018 .